Session Title: Refractive 1
Session Date/Time: Friday 03/02/2012 | 08:30-10:00
Paper Time: 09:41
Venue: Hall 1
First Author: : D.Holland GERMANY
Co Author(s): : M. P D. Hepper D. Holland
Purpose:
To investigate the outcomes for simultaneous correction of presbyopia and ammetropia by biaspherical Presby-Lasik technique based on the creation of a central area hyperpositive for near vision and leaving the midperipheral cornea for far vision with a μ-Monovision concept.
Setting:
36 eyes of 18 patients were treated with the new Presbymax μ-Monovision concept at the Augenklinik Bellevue.
Methods:
All presbyopic patients underwent FEMTO-LASIK and were assessed up to 3 months postoperatively. Mean patient age was 53 years (range: 44-73 years). The preoperatiive sphere ranged from -3,75 to +4,0dpt and the astigmatism from 0 to 4,0dpt. All eyes underwent cornea treatment using the PresbyMAX software delivering bi-aspherical multifocal ablation profiles developed by Schwindt eye-tech-solutions (Kleinostheim, Germany). All Flaps were created by Ziemer LDV Femtolaser (Port, Switzerland). The dominant eye was treated with less addition then the non dominant eye. RESULTS The average mean DUCVA improved from 0.3 to 0.8. The mean NCVA was Nieden 1 and the increased to postoperative NUCVA Nieden 1. The mean postoperative sphere was 0.13dpt and the mean postoperative astigmatism 0.35.
Conclusions:
In presbyopic patients without symptomatic cataract, but refractive errors; PresbyMAX will decrease the presbyopic symptoms and correct far-distance refraction in the same treatment offering spectacle-free vision in daily life in most of the treated patients. Further investigation is necessary to evaluate the overall benefit of this procedure.
Financial Disclosure:
No
